Virtu Financial’s Senti Biosciences Holdings SNTI Stock Holding History

Virtu Financial’s Portfolio SNTI Stock Details SNTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$25K	Buy	+22,795	New	+$22.3K	﹤0.01%	1321
2026 Q1	–	Sell	-44,409	Closed	-$46K	–	2252
2025 Q4	$46K	Buy	+44,409	New	+$78.5K	﹤0.01%	1319
2025 Q1	–	Sell	-13,356	Closed	-$47K	–	1987
2024 Q4	$47K	Buy	+13,356	New	+$42.6K	﹤0.01%	1172
2024 Q2	–	Sell	-1,968	Closed	-$7K	–	1841
2024 Q1	$7K	Buy	+1,968	New	+$8.8K	﹤0.01%	1276
2023 Q3	–	Sell	-3,470	Closed	-$22K	–	1854
2023 Q2	$22K	Buy	+3,470	New	+$33.9K	﹤0.01%	1247
2022 Q3	–	Sell	-2,203	Closed	-$43K	–	2204
2022 Q2	$43K	Buy	+2,203	New	+$177K	﹤0.01%	1161

Other funds holding SNTI

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

MVM

Menlo Ventures Management Menlo Park, California $357M AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Virtu Financial's SNTI Position: Q2 2026 in Review

Virtu Financial opened a new position in Senti Biosciences Holdings (SNTI) in Q2 2026: 22,795 shares worth $25K. The stake represents ﹤0.01% of the portfolio and ranks #1321 among its holdings. This is a return to the name: Virtu Financial previously reported a position in SNTI as recently as Q4 2025.

Virtu Financial first reported a position in SNTI in Q2 2022 and has held it in 6 quarters since. The position peaked at $47K in Q4 2024. 19 funds tracked by Wall St. Rank hold SNTI as of Q2 2026.

Virtu Financial held 22,795 shares of Senti Biosciences Holdings worth $25K as of Q2 2026.
Senti Biosciences Holdings was a new Virtu Financial position in Q2 2026.
Senti Biosciences Holdings made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1321 holding.
Virtu Financial first reported a position in Senti Biosciences Holdings in Q2 2022 and has held it in 6 quarters since.
Virtu Financial's Senti Biosciences Holdings position peaked at $47K in Q4 2024.
19 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.